Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?
AF Costa, AT St-Germain, M Abdolell, RL Smoot… - Clinical radiology, 2017 - Elsevier
Aim To determine whether a combination of clinical factors, the future liver remnant (FLR)
ratio, and hepatic uptake of gadoxetic acid can be used to predict post-hepatectomy liver …
ratio, and hepatic uptake of gadoxetic acid can be used to predict post-hepatectomy liver …
Comparison of clinical outcomes following glue versus polyvinyl alcohol portal vein embolization for hypertrophy of the future liver remnant prior to right hepatectomy
…, SP Cleary, R Smoot, AT St-Germain… - Journal of Vascular and …, 2016 - Elsevier
Purpose To report outcomes after portal vein embolization (PVE) and right hepatectomy in
patients receiving embolization with N-butyl cyanoacrylate (NBCA) glue + central …
patients receiving embolization with N-butyl cyanoacrylate (NBCA) glue + central …
[HTML][HTML] The economics of recovery after pancreatic surgery: detailed cost minimization analysis of an enhanced recovery program
DJ Kagedan, KS Devitt, AT St-Germain, A Ramjaun… - Hpb, 2017 - Elsevier
Background Clinical pathways (CPW) are considered safe and effective at decreasing
postoperative length of stay (LoS), but the effect on economic costs is uncertain. This study sought …
postoperative length of stay (LoS), but the effect on economic costs is uncertain. This study sought …
[HTML][HTML] The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy
AT St-Germain, KS Devitt, DJ Kagedan, B Barretto… - HPB, 2017 - Elsevier
Background Pancreaticoduodenectomies (PD) are complex surgical procedures. Clinical
pathways (CPW) are surgical process improvement tools that guide postoperative recovery …
pathways (CPW) are surgical process improvement tools that guide postoperative recovery …
Management and surveillance of non-functional pancreatic neuroendocrine tumours: retrospective review
L Yohanathan, F Dossa, ATS Germain, F Golbafian… - Pancreatology, 2019 - Elsevier
… Author links open overlay panel Lavanya Yohanathan b , Fahima Dossa a , Amelie Tremblay
St. Germain c , Faegheh Golbafian d , Carol-anne Moulton a e , Ian D. McGilvray a e , Paul …
St. Germain c , Faegheh Golbafian d , Carol-anne Moulton a e , Ian D. McGilvray a e , Paul …
How do different indices of hepatic enhancement with gadoxetic acid compare in predicting liver failure and other major complications after hepatectomy?
AF Costa, AT St-Germain, M Abdolell… - Journal of computer …, 2018 - journals.lww.com
Objective The objective of this study was to assess the accuracy of gadoxetic acid hepatic
enhancement indices in predicting posthepatectomy liver failure (PHLF) and other major …
enhancement indices in predicting posthepatectomy liver failure (PHLF) and other major …
Adenocarcinoma of the Pancreas
A Tremblay St-Germain, S Gallinger… - Surgical Oncology …, 2016 - Springer
Pancreatic cancer is the fifth leading cause of cancer death in Canada with slowly rising
incidence and projections to become the second cause of cancer death by 2020. Diagnosis is …
incidence and projections to become the second cause of cancer death by 2020. Diagnosis is …
Management and surveillance of non-functional pancreatic neuroendocrine tumors: Retrospective review
L Yohanathan, AT St-Germain, F Golbafian, S Temple… - HPB, 2016 - hpbonline.org
Background: Management of small non-functional PNETs remains controversial and may
include radiologic observation for some lesions. Methods: A retrospective review of patients …
include radiologic observation for some lesions. Methods: A retrospective review of patients …
A ten year experience of liver resection combined with major venous reconstruction using hypothermic parenchymal preservation: Is there a learning curve?
K Tomiyama, AT St-Germain, N Goldaracena, R Smoot… - HPB, 2016 - hpbonline.org
Methods: We reviewed 34 consecutive liver with major vascular resections performed using
either in situ hypothermic liver preservation (n= 30) or ex vivo liver resection (n= 4) from …
either in situ hypothermic liver preservation (n= 30) or ex vivo liver resection (n= 4) from …
Major arterial resection for stage 3 adenocarcinoma of the pancreas.
…, K Tomiyama, N Zilbert, A Tremblay St-Germain… - 2018 - ascopubs.org
362 Background: Stage 3 pancreas ductal adenocarcinoma (PDAC) is defined by arterial
involvement, and its resection remains controversial. The objective of this study was to …
involvement, and its resection remains controversial. The objective of this study was to …
